Richmond Pharmacology is excited to announce that Dr. Jörg Taubel, along with colleagues Nobuo Ittetsu and Minoru Takada, will be attending the 21st DIA Japan Annual Meeting 2024. This event, held in Tokyo from 27th to 29th October, brings together global leaders in drug development and regulatory science.

The conference will focus on "Driving Patient-Centric Innovation" and offers a unique opportunity for industry professionals to engage in high-level discussions on the latest advancements in drug development, regulatory trends, and innovative technologies in healthcare.

As an attendee, Dr. Taubel will be contributing to the dialogue on cutting-edge clinical research practices. If you would like to connect with us during the event, please feel free to reach out and arrange a meeting.

For more information about the event, please visit the DIA Japan Annual Meeting 2024 website.

Latest news

Red4Research Blog – Alan’s Story

June 24, 2025
#Red4Research is a global initiative that recognises the essential role of clinical research in improving treatment, outcomes, and the future of medicine.
Read more

Richmond Appoints Lisa Campbell as Director of Regulatory Strategy

April 23, 2025
Richmond Pharmacology is pleased to announce the appointment of Lisa Campbell as Director of Regulatory Strategy
Read more

Events

BIO International Convention 2025

16-19 June 2025
Richmond Pharmacology will be attending the BIO International Convention 2025 in Boston, connecting with biotech innovators at Booth 765.
View event